Inventor · disambiguated record
Todd K. Rosengart
Also filed as: ROSENGART TODD · ROSENGART TODD K
15 granted patents·9 pending applications·763 citations·filing 1996–2022
94Inventor score
Files withCORNELL RES FOUNDATION INC10BAYLOR COLLEGE MEDICINE5ROSENGART TODD K3UNIV CORNELL3ROTHSCHILD MITCHEL1
Top patents by PatentIndex Score
24 records- 0183US6508802B1Remote sensing gene therapy delivery device and method of administering a therapeutic solution to a heartCORNELL RES FOUNDATION INC·Filed 2000·Granted Jan 21, 2003·151 cites·40 claims
- 0283US6322536B1Minimally invasive gene therapy delivery and methodCORNELL RES FOUNDATION INC·Filed 1999·Granted Nov 27, 2001·178 cites·31 claims
- 0374US5846225AGene transfer therapy delivery device and methodCORNELL RES FOUNDATION INC·Filed 1997·Granted Dec 8, 1998·173 cites·14 claims
- 0472US10383916B2Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardiumUNIV CORNELL·Filed 2013·Granted Aug 20, 2019·1 cites·10 claims
- 0571US8694441B1Method for determining the quality of a professionalROTHSCHILD MITCHEL·Filed 2008·Granted Apr 8, 2014·13 cites·24 claims
- 0669US6329348B1Method of inducing angiogenesisCORNELL RES FOUNDATION INC·Filed 1999·Granted Dec 11, 2001·26 cites·21 claims
- 0766US12031135B2p63 inactivation for the treatment of heart failureBAYLOR COLLEGE MEDICINE·Filed 2022·Granted Jul 9, 2024·0 cites·18 claims
- 0866US7255706B2Apparatus and method for cutting a heart valveROSENGART TODD K·Filed 2003·Granted Aug 14, 2007·40 cites·33 claims
- 0966US2022088143A1Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardiumUNIV CORNELL·Filed 2021·Application pending·0 cites
- 1065US5997509AMinimally invasive gene therapy delivery device and methodCORNELL RES FOUNDATION INC·Filed 1998·Granted Dec 7, 1999·109 cites·20 claims
- 1164US2019358297A1Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardiumUNIV CORNELL·Filed 2019·Application pending·0 cites
- 1257US2003103943A1Multiple site delivery of adenoviral vector for the induction of angiogenesisCORNELL RES FOUNDATION INC·Filed 2003·Application pending·0 cites
- 1356US2024324947A1Energy wave refraction and methodology to detect gastric distention and prevent aspirationBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 1455US6518255B2Multiple site delivery of adenoviral vector directly into muscle for the induction of angiogenesisCORNELL RES FOUNDATION INC·Filed 1999·Granted Feb 11, 2003·13 cites·96 claims
- 1554US2024342312A1A shortened p63-protein domain to enhance human cardiac reprogrammingBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 1653US2004047838A1Tissue flap angiogenesisCORNELL RES FOUNDATION INC·Filed 2003·Application pending·0 cites
- 1750US7066953B2Method and apparatus for performing an anastamosisROSENGART TODD K·Filed 2002·Granted Jun 27, 2006·2 cites·54 claims
- 1848US6165754AMethod of expressing an exogenous nucleic acidCORNELL RES FOUNDATION INC·Filed 1999·Granted Dec 26, 2000·12 cites·44 claims
- 1948US2022143142A1Direct reprogramming of cardiac fibroblasts into cardiomyocytes using an endothelial cell transdifferentiation strategyBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 2047US6814751B2Method and apparatus for performing an anastamosisROSENGART TODD K·Filed 2002·Granted Nov 9, 2004·3 cites·49 claims
- 2146US2024115732A1Epicardial Delivery of Gene TherapyXYLOCOR THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2245US11421229B2p63 inactivation for the treatment of heart failureBAYLOR COLLEGE MEDICINE·Filed 2016·Granted Aug 23, 2022·0 cites·40 claims
- 2345US5868764APerfusion and occlusion device and methodCORNELL RES FOUNDATION INC·Filed 1996·Granted Feb 9, 1999·42 cites·17 claims
- 2425US2002076395A1Modified adipose tissue and related implants and methodsFiled 1998·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →